Status: Recruiting
A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
Pivotal trial to evaluate the safety and effectiveness of the TruGamma tricuspid valve replacement system
Participants needed: 180
Trial details
Age: 65+Biological sex: AllType: InterventionalSponsor: Jiangsu Trulive Medical Co., LtdUpdated: Jul 8, 2026Locations: 1
Eligibility criteria
Age ≥65 years old. [+5]
Transesophageal echocardiography (TEE) is contraindicated or cannot be completed... [+29]